Publication | Closed Access

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Phase IiRadiation TherapyGastrointestinal OncologyMedicineNeoadjuvant CapecitabinePathologyCancer TreatmentOncologyRadiation OncologyCancer ResearchCapecitabine-based Chemoradiotherapy